pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,157 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
CBP/p300 Inhibitors
Central Nervous System (CNS) Cancer
Sumitomo Pharma Co Ltd
0 catalysts
Preclinical
CBS-101
Retinitis Pigmentosa (Retinitis)
CIRC Biosciences Inc
0 catalysts
Preclinical
CBT-007
Glaucoma
Cloudbreak Therapeutics LLC
0 catalysts
Preclinical
CBT-145
Presbyopia
← prev
page 9 of 39
next →
131
Pain89
Neurology1
Cloudbreak Therapeutics LLC
0 catalysts
Preclinical
CC-2401
Solid Tumor
CytoCan Corp
0 catalysts
Preclinical
CC-2402
Solid Tumor
CytoCan Corp
0 catalysts
Preclinical
CD6/CTLA4 CAR-Treg-Dermatological Basket
Psoriasis
Immuthera Inc
0 catalysts
Preclinical
CD6/CTLA4 CAR-Treg-Neuro Basket
Amyotrophic Lateral Sclerosis
Immuthera Inc
0 catalysts
Preclinical
CDKN2A Program
Pancreatic Cancer
$IDYAIDEAYA Biosciences, Inc.
0 catalysts
Preclinical
CDX Program
Refractory Acute Myeloid Leukemia
HemoGenyx Pharmaceuticals Plc
0 catalysts
Preclinical
CDX-101
Cardax
Hypertriglyceridemia
Cardax Inc
0 catalysts
Preclinical
CDX-301
Juvenile Macular Degeneration (Stargardt Disease)
Cardax Inc
0 catalysts
Preclinical
CEL-4000
Rheumatoid Arthritis
CEL-SCI Corp
0 catalysts
Preclinical
CEN-501
Allergic Rhinitis
NeuCen BioMed Co Ltd
0 catalysts
Preclinical
CF-602
Erectile Dysfunction
$CANFCan-Fite BioPharma Ltd.
0 catalysts
Preclinical
CG-923308
Breast Cancer
$GYREGYRE THERAPEUTICS, INC.
0 catalysts
Preclinical
CGT-1263
Unspecified Cancer
$COGTCogent Biosciences, Inc.
0 catalysts
Preclinical
CHA-001
decitabine
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Cha Therapeutics Inc
0 catalysts
Preclinical
CHT-103
Hematological Tumor
Nanjing Miracle Biotechnology Co Ltd
0 catalysts
Preclinical
CHT-104
Hematological Tumor
Nanjing Miracle Biotechnology Co Ltd
0 catalysts
Preclinical
CHT-105
Autoimmune Disorders
Nanjing Miracle Biotechnology Co Ltd
0 catalysts
Preclinical
CIB-201
Renal Cell Carcinoma
Cellinfinity Bio Inc
0 catalysts
Preclinical
CIC-39
Duchenne Muscular Dystrophy
ChemIcare Srl
0 catalysts
Preclinical
CIL-05
Primary Ciliary Dyskinesia
Cila Therapeutics Inc
0 catalysts
Preclinical
CIRC-825
Batten Disease
Circumvent Pharmaceuticals Inc
0 catalysts
Preclinical
CKD Program
Diabetic Nephropathy
Arch Biopartners Inc
0 catalysts
Preclinical
CL-04177
Hematological Tumor
Cleara Biotech BV
0 catalysts
Preclinical
CL-04183
Metastatic Colorectal Cancer
Cleara Biotech BV
0 catalysts
Preclinical
CLD-001
Unspecified Hematological Disorders
Celaid Therapeutics Inc
0 catalysts
Preclinical
CLG-001
Mitochondrial Diseases
Cellergy Therapeutics Ltd
0 catalysts